The S&P 500® Top 20 Select Index series launched in August 2024 and is designed to measure the capped market-capitalization-weighted performance of the largest 20 companies, by float market cap, in the S&P 500.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Shares of gaming and hospitality company Boyd Gaming (NYSE:BYD)
jumped 6.8% in the morning session after the company reported strong first-quarter 2025 results, with revenue, EBITDA, and earnings per share all coming in above Wall Street's expectations, despite weather disruptions and a tough comparison to last year's leap year bump. The real story was the 20% jump in online segment revenue, now a vital part of Boyd's growth engine, fueled by higher contributions from digital casino games.
Overall, this quarter had some key positives.
Shares of children’s apparel manufacturer Carter’s (NYSE:CRI)
fell 11.5% in the afternoon session after the company reported weak first-quarter 2025 results, as a narrow beat on adjusted EPS and stronger-than-expected same-store sales were overshadowed by its suspension of forward guidance amid a CEO transition and tariff uncertainty.
Shares of freight transportation and logistics provider Saia (NASDAQ:SAIA)
fell 34.8% in the afternoon session after the company reported weak first-quarter 2025 results, with its revenue and EBITDA both falling short of analysts' estimates, reflecting a tough start to the year. The real story was the sharp sales and profit declines, driven by weather-related disruptions, and weaker-than-expected March shipments.
While revenue ticked up 4%, that modest gain masked deeper issues: growth in tonnage and shipments was undermined by a drop in revenue per unit, especially when excluding fuel surcharges, which fell more than 5%. The lack of typical seasonal acceleration in March also weighed heavily on performance. Overall, this was a softer quarter.
The company’s lead candidate, ivonescimab, aimed at treating certain cancers, was discovered by Akeso and is currently in multiple late-stage clinical trials.
The week so far has been a battle against broadly favorable Central U.S. and Brazilian weather against potential record-low old crop exporter stocks/use and unhindered near-term U.S. export demand.
Intel reports strong Q1 results but faces stock decline due to tariff concerns and uncertain revenue forecasts. New CEO Lip-Bu Tan plans cost-cutting measures to enhance efficiency amid economic challenges.
B Of A Securities analyst raised the price forecast for GE Aerospace from $225 to $230 while retaining a Buy rating. GE reported strong Q1 results and expects continued growth, with potential tariff risks. Analyst raised EPS estimates and suggested potential ETF investments.
Electronic system and device provider Bel Fuse (NASDAQ:BELFA) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 18.9% year on year to $152.2 million. Its GAAP profit of $1.36 per share was 64.8% above analysts’ consensus estimates.
Bitcoin (CRYPTO: BTC) mining expenses rose sharply in the final quarter of 2024, with CoinShares reporting that the total average cost to produce one Bitcoin, including non-cash items, climbed to $137,018.
President Donald Trump's steep tariffs on Chinese imports could lead to empty store shelves and shortages for consumers in the coming weeks, experts warn.
Steve Benz, legal and US general counsel of Novo Nordisk, said the company is “pleased” that the court rejected the compounders' attempts to “undermine” the FDA's decision that the shortages of Wegovy and Ozempic have been resolved.
